PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
Author:
Funder
Intramural Program of the Center for Cancer Research, National Cancer Institute
National Institutes of Health
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/25/1/32/391009/mdt384.pdf
Reference73 articles.
1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1;Miki;Science,1994
2. Identification of the breast cancer susceptibility gene BRCA2;Wooster;Nature,1995
3. The Cancer Genome Atlas Network. Integrated genomic analyses of ovarian carcinoma;Nature,2011
4. The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours;Nature,2012
5. Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects;Evers;Oncogene,2006
Cited by 287 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors;Redox Biology;2024-10
2. The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities;Current Oncology;2024-07-01
3. IB-DNQ and Rucaparib dual treatment alters cell cycle regulation and DNA repair in triple negative breast cancer cells;2024-05-18
4. Untypical bilateral breast cancer with peritoneal fibrosis on 18F-FDG PET/CT: case report and literature review;Frontiers in Medicine;2024-04-29
5. Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection;Cancer Treatment Reviews;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3